-
Signature
-
/s/ Allein Sabel, Attorney-in-Fact
-
Issuer symbol
-
MSTR
-
Transactions as of
-
11 Mar 2026
-
Net transactions value
-
-$125,725
-
Form type
-
4
-
Filing time
-
13 Mar 2026, 16:05:03 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Kang Andrew |
EVP & CFO |
C/O STRATEGY INC, 1850 TOWERS CRESCENT PLAZA, TYSONS CORNER |
/s/ Allein Sabel, Attorney-in-Fact |
13 Mar 2026 |
0001825170 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MSTR |
Class A Common Stock |
Options Exercise |
|
+2,071 |
+9.1% |
|
24,731 |
11 Mar 2026 |
Direct |
F1 |
| transaction |
MSTR |
Class A Common Stock |
Sale |
$125,725 |
-916 |
-3.7% |
$137.25 |
23,815 |
12 Mar 2026 |
Direct |
F2 |
| holding |
MSTR |
Series A Perpetual Strife Preferred Stock |
|
|
|
|
|
1,500 |
11 Mar 2026 |
Direct |
|
| holding |
MSTR |
Series A Perpetual Stretch Preferred Stock |
|
|
|
|
|
2,800 |
11 Mar 2026 |
Direct |
|
| holding |
MSTR |
Series A Perpetual Stride Preferred Stock |
|
|
|
|
|
2,250 |
11 Mar 2026 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MSTR |
Restricted Stock Units |
Options Exercise |
|
-2,071 |
-25% |
$0.000000* |
6,213 |
11 Mar 2026 |
Class A Common Stock |
2,071 |
|
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: